Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease.
Di Pardo A, Amico E, Basit A, Armirotti A, Joshi P, Neely MD, Vuono R, Castaldo S, Digilio AF, Scalabrì F, Pepe G, Elifani F, Madonna M, Jeong SK, Park BM, D'Esposito M, Bowman AB, Barker RA, Maglione V.
Di Pardo A, et al. Among authors: pepe g.
Sci Rep. 2017 Jul 13;7(1):5280. doi: 10.1038/s41598-017-05709-y.
Sci Rep. 2017.
PMID: 28706199
Free PMC article.